欢迎来到天天文库
浏览记录
ID:12147451
大小:29.00 KB
页数:0页
时间:2018-07-15
《进展期胃癌术中行区域性缓释化疗安全性评价》由会员上传分享,免费在线阅读,更多相关内容在学术论文-天天文库。
1、进展期胃癌术中行区域性缓释化疗安全性评价【摘要】目的探讨进展期胃癌术中腹腔内行区域性植入5�氟尿嘧啶缓释化疗的临床疗效及用药安全进行分析评价。方法将60例进展期胃癌患者均进行手术根治切除术后并随机分为两组,治疗组:30例患者给予术中行区域性缓释化疗;对照组30例患者与治疗组患者术后均进行常规全身化疗,并对其两组患者治疗后临床疗效进行疗效评价及安全性评价。结果疗效判定治疗组:完全缓解8例占26�7%、部分缓解11例占36�7%、疾病稳定7例占23�3%、疾病进展4例占13�3%。对照组:完全缓解5例占1�7%、部分缓解9例占30�0%、疾病稳定11例占
2、36�7%、疾病进展5例占16�7%。两组患者在治疗后腹腔相关并发症与化疗毒副作用无显著差异。结论进展期胃癌术中腹腔内行区域性植入5�氟尿嘧啶缓释化疗,患者耐受性良好,用药后临床疗效增加而未见明显的全身、局部不良反应。【关键词】进展期胃癌;区域缓释化疗;5�氟尿嘧啶缓释剂;疗效评价;不良反应Advancedgastriccancerintraoperativeregionalsafetyevaluationofsustained�releasechemotherapyHEXing�chang.DepartmetnofGeneral5SurgeryTh
3、eFirstPeople�sHospitalofShangqiucity476100,China【Abstract】ObjectiveTodiscussadvancedgastriccancerimplantedintheabdominalcavityofregionalexperts5�Fluorouracilchemotherapyefficacyandsustained�releasedrugsafetyanalysisandevaluation�Methods60casesofadvancedgastriccancerpatientsunde
4、rwentradicalsurgicalresectionwererandomlydividedintotreatmentgroups:30patientsweretreatedwithintraoperativeregionalslow�releasechemotherapy,controlgroupof30patientswithtreatmentgrouppatientsareroutinechemotherapy,andtwogroupsofpatientsaftertheirclinicalefficacyevaluationandsafe
5、tyevaluation�ResultsDeterminetheefficacyofthetreatmentgroups:completeremissionin8casesaccountedfor26�7%,partialresponse11casesaccountedfor36�7%,sevencasesofstabledisease23�3%,diseaseprogressionwasfourcases(13�3%)�Controlgroup:5caseswere(1�7%)completeremission,partialremissionin
6、9cases5accountedfor30�0%,stabledisease11casesaccountedfor36�7%,diseaseprogression,fivecasesof16�7%�Twogroupsofpatientsafterabdominal�relatedcomplicationsinthetreatmentofchemotherapysideeffectswithnosignificantdifference�ConclusionAdvancedgastriccancersurgeryintheabdominalcavity
7、implantationofregionalexperts5�Fluorouracilsustained�releasechemotherapy,thepatientiswelltolerated,clinicalefficacyaftertreatmentnosignificantincreaseinsystemicandlocaladversereactions.【Keywords】Advancedgastriccancer;Regionalreleasechemotherapy;5�Fluorouracilreleaseagent;Evalua
8、tion;Adversereactions作者单位:476100河南省商丘市第一人民医院普外科胃癌仍属于人类
此文档下载收益归作者所有